Temporal change in prevalence and complications of uveitis associated with juvenile idiopathic arthritis: Data from a cross-sectional analysis of a prospective nationwide study

Clinical and Experimental Rheumatology

Volumn 33, Issue 6, 2015, Pages 936-944

  Tappeiner, Christoph ^a,c   Klotsche, Jens ^a,d   Schenck, Sandra ^a   Niewerth, Martina ^a   Minden, Kirsten ^a,d   Heiligenhaus, Arnd ^b,e  

^a Leibniz Institute   (Germany)

^b ST FRANZISKUS HOSPITAL   (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Complications; Disease modifying anti rheumatic drugs; Immunosuppressives; Juvenile idiopathic arthritis; Population based study; Prevalence; Temporal change; Uveitis

Indexed keywords

ANTIRHEUMATIC AGENT;

ADOLESCENT; ARTHRITIS, JUVENILE; CHILD; CLINICAL TRIAL; COMPLICATION; CROSS-SECTIONAL STUDY; FACTUAL DATABASE; FEMALE; GERMANY; HUMAN; MALE; MULTICENTER STUDY; ONSET AGE; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; TIME; UVEITIS;

ADOLESCENT; AGE OF ONSET; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE; CHILD; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; FEMALE; GERMANY; HUMANS; MALE; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; UVEITIS;

EID: 84957937707     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. HEILIGENHAUS A, HEINZ C, EDELSTEN C, KOTANIEMI K, MINDEN K: Review for disease of the year: epidemiology of juvenile idiopathic arthritis and its associated uveitis: the probable risk factors. Ocul Immunol Inflamm 2013; 21:180-91.
2. MINDEN K, MINGELS A, NIEWERTH M, HEILIGENHAUS A, GANSER G: [Juvenile idiopathic arthritis and uveitis: epidemiology including data from a national database]. Klin Monbl Augenheilkd 2007; 224: 469-72.
3. BERNTSON L, ANDERSSON GÄRE B, FASTH A et al.: Incidence of juvenile idiopathic arthritis in the Nordic countries. A population based study with special reference to the validity of the ILAR and EULAR criteria. J Rheumatol 2003; 30: 2275-82.
4. DANNER S, SORDET C, TERZIC J et al.: Epidemiology of juvenile idiopathic arthritis in Alsace, France. J Rheumatol 2006; 33: 1377-81.
5. PRUUNSILD C, UIBO K, LIIVAMÄGI H, TARRASTE S, TALVIK T, PELKONEN P: Incidence of juvenile idiopathic arthritis in children in Estonia: a prospective population-based study. Scand J Rheumatol. Informa UK Ltd UK 2007; 36: 7-13.
6. PRUUNSILD C, UIBO K, LIIVAMÄGI H, TARRASTE S, TALVIK T, PELKONEN P: Prevalence and short-term outcome of juvenile idiopathic arthritis: a population-based study in Estonia. Clin Exp Rheumatol 2007; 25: 649-53.
7. RIISE OR, HANDELAND KS, CVANCAROVA M et al.: Incidence and characteristics of arthritis in Norwegian children: a population-based study. Pediatrics. American Academy of Pediatrics 2008; 121: e299-306.
8. SOLAU-GERVAIS E, ROBIN C, GAMBERT C et al.: Prevalence and distribution of juvenile idiopathic arthritis in a region of Western France. Joint Bone Spine 2010; 77: 47-9.
9. MODESTO C, ANTÓN J, RODRIGUEZ B et al.: Incidence and prevalence of juvenile idiopathic arthritis in Catalonia (Spain). Scand J Rheumatol 2010; 39: 472-9.
10. SAVOLAINEN E, KAIPIAINEN-SEPPÄNEN O, KRÖGER L, LUOSUJÄRVI R: Total incidence and distribution of inflammatory joint diseases in a defined population: results from the Kuopio 2000 arthritis survey. J Rheumatol 2003; 30: 2460-8.
11. MARTÍNEZ MENGUAL L, FERNÁNDEZ MENÉNDEZ JM, SOLÍS SÁNCHEZ G, FERNÁNDEZ DÍAZ M, FERNÁNDEZ GONZÁLEZ N, MÁLAGA GUERRERO S: [Epidemiological study of juvenile idiopathic arthtitis in the last sixteen years in Asturias (Spain)]. An Pediatr (Barc) 2007; 66: 24-30.
12. KOTANIEMI K, AHO K, KOTANIEMI A: Uveitis as a cause of visual loss in arthritides and comparable conditions. J Rheumatol 2001; 28: 309-12.
13. CARVOUNIS PE, HERMAN DC, CHA S, BURKE JP: Incidence and outcomes of uveitis in juvenile rheumatoid arthritis, a synthesis of the literature. Graefes Arch Clin Exp Ophthalmol 2006; 244: 281-90.
14. HEILIGENHAUS A, NIEWERTH M, GANSER G, HEINZ C, MINDEN K, GERMAN UvEITis IN Childhood study Group: Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology (Oxford) 2007; 46: 1015-9.
15. BENEZRA D, COHEN E, BEHAR-COHEN F: Uveitis and juvenile idiopathic arthritis: A cohort study. Augenspiegel 2007; 1: 513-8.
16. CHALOM EC, GOLDSMITH DP, KOEHLER MA et al.: Prevalence and outcome of uveitis in a regional cohort of patients with juvenile rheumatoid arthritis. J Rheumatol 1997; 24: 2031-4.
17. AKDUMAN L, KAPLAN HJ, TYCHSEN L: Prevalence of uveitis in an outpatient juvenile arthritis clinic: onset of uveitis more than a decade after onset of arthritis. J Pediatr Ophthalmol Strabismus 1997; 34: 101-6.
18. BOONE MI, MOORE TL, CRUZ OA: Screening for uveitis in juvenile rheumatoid arthritis. J Pediatr Ophthalmol Strabismus 1998; 35: 41-3.
19. BOWYER SL, ROETTCHER PA, HIGGINS GC et al.: Health status of patients with juvenile rheumatoid arthritis at 1 and 5 years after diagnosis. J Rheumatol 2003; 30: 394-400.
20. CASSIDY JT, LEVINSON JE, BASS JC et al.: A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum 1986; 29: 274-81.
21. SABRI K, SAURENMANN RK, SILVERMAN ED, LEVIN AV: Course, complications, and outcome of juvenile arthritis-related uveitis. J AAPOS 2008; 12: 539-45.
22. DANA MR, MERAYO-LLOVES J, SCHAUMBERG DA, FOSTER CS: Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis. Ophthalmology 1997; 104: 236-44.
23. DE BOER J, WULFFRAAT N, ROTHOVA A: Visual loss in uveitis of childhood. Br J Ophthalmol 2003; 87: 879-84.
24. ZANNIN ME, BIROLO C, GERLONI VM et al.: Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry. J Rheumatol 2013; 40: 74-9.
25. WORETA F, THORNE JE, JABS DA, KEDHAR SR, DUNN JP: Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol 2007; 143: 647-55.
26. THORNE JE, WORETA F, KEDHAR SR, DUNN JP, JABS DA: Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol 2007; 143: 840-6.
27. EDELSTEN C, REDDY MA, STANFORD MR, GRAHAM EM: Visual loss associated with pediatric uveitis in english primary and referral centers. Am J Ophthalmol 2003; 135: 676-80.
28. KOTANIEMI K, KAIPIAINEN-SEPPÄNEN O, SAVOLAINEN A, KARMA A: A population-based study on uveitis in juvenile rheumatoid arthritis. Clin Exp Rheumatol 1999; 17: 119-22.
29. PÄIVÖNSALO-HIETANEN T, TUOMINEN J, SAARI KM: Uveitis in children: population-based study in Finland. Acta Ophthalmol Scand 2000; 78: 84-8.
30. KOTANIEMI K, SIHTO-KAUPPI K: Occurrence and management of ocular hypertension and secondary glaucoma in juvenile idiopathic arthritis-associated uveitis: An observational series of 104 patients. Augenspiegel 2007; 1: 455-9.
31. SAURENMANN RK, ROSE JB, TYRRELL P et al.: Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor. Arthritis Rheum 2007; 56: 197484.
32. SHERRY DD, MELLINS ED, WEDGWOOD RJ: Decreasing severity of chronic uveitis in children with pauciarticular arthritis. Am J Dis Child 1991; 145: 1026-8.
33. LEE DH, DAUD U, WIPFL J, PEPMUELLER PH, DAVITT BV, MOORE TL: The decreasing prevalence of uveitis associated with juvenile rheumatoid arthritis: do NSAIDs play a role? J Clin Rheumatol 2003; 9: 151-5.
34. PAPADOPOULOU C, KOSTIK M, BÖHM M et al.: Methotrexate therapy may prevent the onset of uveitis in juvenile idiopathic arthritis. J Pediatr 2013; 163: 879-84.
35. BRUNNER HI, KIM KN, BALLINGER SH et al.: Current medication choices in juvenile rheumatoid arthritis II--update of a survey performed in 1993. J Clin Rheumatol 2001; 7: 295-300.
36. OLSON NY, LINDSLEY CB, GODFREY WA: Nonsteroidal anti-inflammatory drug therapy in chronic childhood iridocyclitis. Am J Dis Child 1988; 142: 1289-92.
37. BOLT IB, CANNIZZARO E, SEGER R, SAURENMANN RK: Risk factors and longterm outcome of juvenile idiopathic arthritis-associated uveitis in Switzerland. J Rheumatol 2008; 35: 703-6.
38. CHIA A, LEE V, GRAHAM EM, EDELSTEN C: Factors related to severe uveitis at diagnosis in children with juvenile idiopathic arthritis in a screening program. Am J Ophthalmol 2003; 135: 757-62.
39. SAURENMANN RK, LEVIN AV, FELDMAN BM et al.: Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study. Arthritis Rheum 2007; 56: 647-57.
40. KOTANIEMI K, SIHTO-KAUPPI K, SALOMAA P, SÄILÄ H, RISTOLAINEN L, KAUPPI M: The frequency and outcome of uveitis in patients with newly diagnosed juvenile idiopathic arthritis in two 4-year cohorts from 1990-1993 and 2000-2003. Clin Exp Rheumatol 2014; 32: 143-7.
41. PETTY RE, SOUTHWOOD TR, MANNERS P et al.: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31: 390-2.
42. JABS DA, NUSSENBLATT RB, ROSENBAUM JT, standardization of uveitis nomenclature (sun) working Group: Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol Elsevier 2005; 140: 509-16.
43. ANGELES-HAN ST, PELAJO CF, VOGLER LB et al.: Risk markers of juvenile idiopathic arthritis-associated uveitis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry. J Rheumatol 2013; 40: 2088-96.
44. CARVOUNIS PE, HERMAN DC, CHA SS, BURKE JP: Ocular manifestations of juvenile rheumatoid arthritis in Olmsted County, Minnesota: a population-based study. Graefes Arch Clin Exp Ophthalmol 2005; 243: 217-21.
45. FLATO B, LIEN G, SMERDEL A et al.: Prognostic factors in juvenile rheumatoid arthritis: a case-control study revealing early predictors and outcome after 14.9 years. JRheumatol 2003; 30: 386-93.
46. KUNNAMO I, KALLIO P, PELKONEN P: Incidence of arthritis in urban Finnish children. A prospective study. Arthritis Rheum 1986; 29: 1232-8.
47. CHANDRASEKARAN AN, RAJENDRAN CP MADHAVAN R: Juvenile rheumatoid arthritis-Madras experience. Indian J Pediatr 1996 Jul; 63: 501-10.
48. FUJIKAWA S, OKUNI M: Clinical analysis of 570 cases with juvenile rheumatoid arthritis: results of a nationwide retrospective survey in Japan. Acta Paediatr Jpn 1997; 39: 245-9.
49. PORKODI R, SUBRAMANIAM R, KRISHNAMURTHY V, MADHAVAN R, PARTHIBAN M, CHANDRASEKARAN AN: Pattern of rheumatic diseases in south India. IV. Clinical profile of juvenile rheumatoid arthritis. J Assoc Physicians India 1990; 38: 771-3.
50. SETH V, KABRA SK, SEMWAL OP, JAIN Y: Clinico-immunological profile in juvenile rheumatoid arthritis--an Indian experience. Indian J Pediatr 1996; 63: 293-300.
51. SINGH S, SALARIA M, KUMAR L, MINZ R, DATTA U, SEHGAL S: Clinico-immunological profile of juvenile rheumatoid arthritis at Chandigarh. Indian Pediatr 1999; 36: 449-54.
52. WU CJ, HUANG JL, YANG MH, YAN DC, OU LS, HO HH: Clinical characteristics of juvenile rheumatoid arthritis in Taiwan. J Microbiol Immunol Infect 2001; 34: 211-4.
53. HEILIGENHAUS A, NIEWERTH M, MINGELS A et al.: [Epidemiology of uveitis in juvenile idiopathic arthritis from a national paediatric rheumatologic and ophthalmologic database]. Klin Monbl Augenheilkd 2005; 222: 993-1001.
54. OREN B, SEHGAL A, SIMON JW et al.: The prevalence of uveitis in juvenile rheumatoid arthritis. J AAPOS 2001; 5: 2-4.
55. CHEN CS, ROBERTON D, HAMMERTON ME: Juvenile arthritis-associated uveitis: visual outcomes and prognosis. Can J Ophthalmol 2004; 39: 614-20.
56. PAROLI MP, SPERANZA S, MARINO M, PIRRAGLIA MP, PIVETTI-PEZZI P: Prognosis of juvenile rheumatoid arthritis-associated uveitis. Eur J Ophthalmol 2003; 13: 616-21.
57. TUGAL-TUTKUN I, HAVRLIKOVA K, POWER WJ, FOSTER CS: Changing patterns in uveitis of childhood. Ophthalmology 1996; 103: 375-83.
58. ROSENBERG KD, FEUER WJ, DAVIS JL: Ocular complications of pediatric uveitis. Ophthalmology 2004; 111: 2299-306.
59. WOLF MD, LICHTER PR, RAGSDALE CG: Prognostic factors in the uveitis of juvenile rheumatoid arthritis. Ophthalmology 1987; 94: 1242-8.
60. KOTANIEMI K, KAUTIAINEN H, KARMA A, AHO K: Occurrence of uveitis in recently diagnosed juvenile chronic arthritis: a prospective study. Ophthalmology 2001; 108: 2071-5.
61. KANSKI JJ, SHUN-SHIN GA: Systemic uveitis syndromes in childhood: an analysis of 340 cases. Ophthalmology 1984; 91: 1247-52.
62. SIJSSENS KM, ROTHOVA A, BERENDSCHOT TTJM, DE BOER JH: Ocular hypertension and secondary glaucoma in children with uveitis. Ophthalmology 2006; 113: 853-9.e2.
63. ARGUEDAS O, FASTH A, ANDERSSON-GARE B, PORRAS O: Juvenile chronic arthritis in urban San José, Costa Rica: a 2 year prospective study. J Rheumatol 1998; 25: 1844-50.
64. OZDAL PC, VIANNA RNG, DESCHÊNES J: Visual outcome of juvenile rheumatoid arthritis-associated uveitis in adults. Ocul Immunol Inflamm 2005; 13: 33-8.
65. MA J, CHEN X-M: [Dynamic changes of configuration and position of human ciliary body during accommodation]. Zhonghua Yan Ke Za Zhi 2004; 40: 590-6.
66. KALININA AYUSO V, CATE TEN HAT, VAN DER DOES P, ROTHOVA A, DE BOER JH: Male gender and poor visual outcome in uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol 2010; 149: 987-93.
67. KALININA AYUSO V, CATE TEN HAT, VAN DER DOES P, ROTHOVA A, DE BOER JH: Male gender as a risk factor for complications in uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol 2010; 149: 994-5.
68. HOLLAND GN, DENOVE CS, YU F: Chronic anterior uveitis in children: clinical characteristics and complications. Am J Ophthalmol Elsevier 2009; 147: 667-678.e5.
69. HEILIGENHAUS A, MICHELS H, SCHUMACHER C et al.: Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis. Rheumatol Int 2012; 1121-33.
70. CONSOLARO A, RUPERTO N, BAZSO A et al.: Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum 2009; 61: 658-66.